It is noteworthy that nowadays some of the abovementioned enzymes including aspartic proteases, glutathione-S-transferase are clearly identified as potential new targets for drug discovery against malaria and several others metabolic dysfunctions of public health significance including cancer, obesity, epilepsy and gout. The gene discussed is HPGDS; the disease is obesity due to melanocortin 4 receptor deficiency.